Alcon Net Income 2019-2025 | ALC

Alcon annual/quarterly net income history and growth rate from 2019 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Alcon net income for the quarter ending March 31, 2025 was $350M, a 41.13% increase year-over-year.
  • Alcon net income for the twelve months ending March 31, 2025 was $1.120B, a 6.87% increase year-over-year.
  • Alcon annual net income for 2024 was $1.018B, a 4.52% increase from 2023.
  • Alcon annual net income for 2023 was $0.974B, a 190.75% increase from 2022.
  • Alcon annual net income for 2022 was $0.335B, a 10.9% decline from 2021.
Alcon Annual Net Income
(Millions of US $)
2024 $1,018
2023 $974
2022 $335
2021 $376
2020 $-531
2019 $-656
2018 $-227
Alcon Quarterly Net Income
(Millions of US $)
2025-03-31 $350
2024-12-31 $284
2024-09-30 $263
2024-06-30 $223
2024-03-31 $248
2023-12-31 $427
2023-09-30 $204
2023-06-30 $169
2023-03-31 $174
2022-12-31 $-97
2022-09-30 $116
2022-06-30 $148
2022-03-31 $168
2021-12-31 $139
2021-09-30 $2
2021-06-30 $151
2021-03-31 $84
2020-12-31 $95
2020-09-30 $-147
2020-06-30 $-422
2020-03-31 $-57
2019-12-31 $-91
2019-09-30 $-66
2019-06-30 $-390
2019-03-31 $-109
2018-12-31
2018-09-30 $-207
2018-06-30 $15
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.878B $9.911B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $200.019B 87.61
Thermo Fisher Scientific (TMO) United States $150.378B 18.19
Edwards Lifesciences (EW) United States $45.620B 29.91
IDEXX Laboratories (IDXX) United States $41.997B 48.26
DexCom (DXCM) United States $33.619B 51.96
IQVIA Holdings (IQV) United States $25.495B 14.28
Mettler-Toledo (MTD) United States $24.204B 28.78
STERIS (STE) Ireland $23.962B 26.39
Waters (WAT) United States $20.610B 29.08
SONOVA HOLDING (SONVY) Switzerland $18.452B 0.00
Hologic (HOLX) United States $14.055B 15.27
Sysmex ADR (SSMXY) Japan $10.248B 29.07
Penumbra (PEN) United States $10.006B 78.54
Masimo (MASI) United States $8.931B 32.94
Globus Medical (GMED) United States $8.062B 19.21
Teleflex (TFX) United States $5.411B 8.93
Glaukos (GKOS) United States $5.296B 0.00
TransMedics (TMDX) United States $4.586B 99.70
Integer Holdings (ITGR) United States $4.218B 22.10
PROCEPT BioRobotics (PRCT) United States $3.599B 0.00
LivaNova (LIVN) United Kingdom $2.445B 14.56
Nihon Kohden (NHNKY) Japan $2.253B 25.84
Veracyte (VCYT) United States $2.113B 29.65
Elekta AB (EKTAY) Sweden $1.973B 17.74
Alphatec Holdings (ATEC) United States $1.818B 0.00
Tandem Diabetes Care (TNDM) United States $1.376B 0.00
Artivion (AORT) United States $1.244B 116.48
Pulse Biosciences (PLSE) United States $1.098B 0.00
OPKO Health (OPK) United States $1.086B 0.00
Integra LifeSciences Holdings (IART) United States $1.033B 5.49
Beta Bionics (BBNX) United States $0.848B 0.00
SiBone (SIBN) United States $0.812B 0.00
IRadimed (IRMD) United States $0.767B 38.94
RxSight (RXST) United States $0.606B 0.00
Delcath Systems (DCTH) United States $0.588B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.570B 8.87
Mesa Laboratories (MLAB) United States $0.544B 12.76
OrthoPediatrics (KIDS) United States $0.507B 0.00
AxoGen (AXGN) United States $0.492B 0.00
AngioDynamics (ANGO) United States $0.445B 0.00
NeuroPace (NPCE) United States $0.436B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.420B 0.00
Semler Scientific (SMLR) United States $0.364B 9.69
Treace Medical Concepts (TMCI) United States $0.363B 0.00
ClearPoint Neuro (CLPT) United States $0.359B 0.00
Pacific Biosciences Of California (PACB) United States $0.300B 0.00
Neuronetics (STIM) United States $0.252B 0.00
908 Devices (MASS) United States $0.240B 0.00
Tactile Systems Technology (TCMD) United States $0.235B 14.24
Sight Sciences (SGHT) United States $0.217B 0.00
Alpha Tau Medical (DRTS) Israel $0.198B 0.00
Anteris Technologies Global (AVR) Australia $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
Inogen (INGN) United States $0.169B 0.00
CVRx (CVRX) United States $0.168B 0.00
Biosig Technologies (BSGM) United States $0.157B 0.00
Accuray (ARAY) United States $0.157B 0.00
Rapid Micro Biosystems (RPID) United States $0.155B 0.00
LENSAR (LNSR) United States $0.154B 0.00
Lucid Diagnostics (LUCD) United States $0.131B 0.00
Atossa Genetics (ATOS) United States $0.111B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.090B 0.00
Sensus Healthcare (SRTS) United States $0.083B 50.30
InspireMD (NSPR) United States $0.077B 0.00
EDAP TMS S.A (EDAP) France $0.068B 0.00
Hyperfine (HYPR) United States $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.061B 0.00
Positron (POSC) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Spectral AI (MDAI) United States $0.045B 0.00
Precision Optics (POCI) United States $0.034B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
Baird Medical Investment Holdings (BDMD) $0.028B 0.00
NexGel (NXGL) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.37
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00